What is the current Mediwound market capitalization?
The current market capitalization of Mediwound is 180.43 M USD.
Mediwound Market capitalization 2025
Mediwound Market capitalization
180.43 M USD
Ticker
MDWD
ISIN
IL0011316309
WKN
A110TG
In 2025, Mediwound's market cap stood at 180.43 M USD, a 6.83% increase from the 168.9 M USD market cap in the previous year.
The Mediwound Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2024 | 163.82 |
| 2023 | 93.48 |
| 2022 | 65.01 |
| 2021 | 111.1 |
| 2020 | 82.1 |
| 2019 | 103.89 |
| 2018 | 153.41 |
| 2017 | 137.63 |
| 2016 | 157.72 |
| 2015 | 161.96 |
| 2014 | 176.71 |
| 2013 | - |
| 2012 | - |
| 2011 | - |
Mediwound Aktienanalyse
What does Mediwound do?
Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Mediwound's Market Capitalization
Mediwound's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Mediwound's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Mediwound's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Mediwound’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Mediwound stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Mediwound.
How has the market capitalization of Mediwound developed in recent years?
The market capitalization of Mediwound has increased/decreased by 6.83% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Mediwound?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Mediwound?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Mediwound have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Mediwound pay?
Over the past 12 months, Mediwound paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mediwound is expected to pay a dividend of 0 USD.
What is the dividend yield of Mediwound?
The current dividend yield of Mediwound is .
When does Mediwound pay dividends?
Mediwound pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Mediwound?
Mediwound paid dividends every year for the past 0 years.
What is the dividend of Mediwound?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Mediwound located?
Mediwound is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mediwound kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mediwound from 8/16/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/16/2025.
When did Mediwound pay the last dividend?
The last dividend was paid out on 8/16/2025.
What was the dividend of Mediwound in the year 2024?
In the year 2024, Mediwound distributed 0 USD as dividends.
In which currency does Mediwound pay out the dividend?
The dividends of Mediwound are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Mediwound
Our stock analysis for Mediwound Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediwound Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
